$4.77
-0.07-1.45%
Last update: Nov 10, 6:26 AM
ENDRA Life Sciences Inc
NDRANASDAQ
ENDRA Life Sciences fell 15.3% from $5.63 to $4.77, behind the S&P 500's +9.8%. Its worst day was Jun 25 (−30.5%), and its low came Mar 19 at $3.26.
Story events cover the past 12 months · Times ET
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-2.10 missed the $-1.95 estimate on $0.00 revenue.
−7.5% · S&P 500 −0.9%
ENDRA Life Sciences closed at its lowest level of the year, 42.1% below where the year started.
−4.4% · S&P 500 −0.5%
EPS of $-3.25 missed the $-1.23 estimate on $0.00 revenue.
0.0% · S&P 500 +0.8%
ENDRA Life Sciences shares rose 22.1%, while the S&P 500 rose 1.2%.
+22.1% · S&P 500 +1.2%
EPS of $-1.09 beat the $-1.23 estimate on $0.00 revenue.
+7.1% · S&P 500 −0.1%
ENDRA Life Sciences shares fell 30.5%, while the S&P 500 rose 0.1%.
−30.5%, the year's worst day · S&P 500 +0.1%
EPS of $0.06 beat the $-0.84 estimate on $0.00 revenue.
+0.4% · S&P 500 −0.5%
ENDRA Life Sciences shares rose 22.6%, while the S&P 500 rose 0.4%.
+22.6%, the year's best day · S&P 500 +0.4%
Where it ended: a close of $4.77 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.84).
Nothing in the past 12 months.
All NDRA dividend history
